Clinical Trials
11 trialsNCT03443492 2025-12-30
Pancreas
National Health Research Institutes, Taiwan
Phase 2 Completed
NCT00651742 2024-09-19
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Taiho Oncology, Inc.
Phase 2 Completed
NCT00652054 2024-09-03
Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer
Taiho Oncology, Inc.
Phase 2 Completed
NCT03162510 2022-04-07
SOLAR
National Health Research Institutes, Taiwan
Phase 1 Completed
NCT02131493 2022-03-02
S-1 and and Gemcitabine vs Gemcitabine Alone as Adjuvant Chemotherapy for Patients With Resected Pancreatic Cancer
Zhejiang University
Phase 2 Completed
NCT02459652 2020-10-27
Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer
Japan Adjuvant Study Group of Pancreatic Cancer
Phase 2 Completed
NCT02704143 2020-10-19
Combination of SBRT With Sequential S-1 for Treating Locally Advanced Pancreatic Cancer
Changhai Hospital
Phase NA Completed
NCT01781520 2018-01-18
Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer
Capital Medical University
Phase 1/2 Completed
NCT01430052 2017-11-21
Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer
Osaka Medical Center for Cancer and Cardiovascular Diseases
Phase 2 Completed
NCT01693419 2017-08-23
S-1, Gemcitabine and Erlotinib for Advanced Pancreatic Cancer
Hallym University Medical Center
Phase 2 Completed
NCT00514163 2011-06-28
GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
Japan Clinical Cancer Research Organization
Phase 2 Completed